Colbeck Capital Management Provides $125 Million in Financing to Specialty Pharmaceutical Company
Colbeck Capital Management has provided a $125 million senior secured acquisition facility to a specialty pharmaceutical company focused on commercializing branded and prescription drugs for the U.S. market. The company and its affiliate, a pharmaceutical manufacturing and packaging organization, operate as a premier supplier of difficult to source products in retail and institutional pharmacy.
Proceeds from the facility were used to expand the company’s portfolio of branded generics, building a robust pipeline of specialty products to accelerate the company’s market growth.
Colbeck Capital Management has extensive experience providing strategic financing to expand companies’ market reach and deliver timely growth opportunities.